ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C09DX01 | B | Valsartan - 160mg, Amlodipine - 5mg, Hydrochlorothiazide - 25mg | 11779 | 138123/1 | EXFORGE HCT | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Novartis Farma SpA | Italy | 1,333,092 L.L | 23.08 | A2 | Novartis Pharma AG | Switzerland | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C09DX01 | G | Valsartan - 160mg, Amlodipine - 5mg, Hydrochlorothiazide - 25mg | 11337 | 9922/1 | VIOSTAN AM PLUS 160/5/25 | 30 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 1,196,020 L.L | 23.08 | B | 2/5/2024 | 0 |